DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.

Cell Death & Disease
Chin-Hui LaiHao Hu

Abstract

Bladder cancer is one of the most commonly diagnosed malignant tumors in the urinary system and causes a massive cancer-related death. DEPDC1B is a DEP domain-containing protein that has been found to be associated with a variety of human cancers. This study aimed to explore the role and mechanism of DEPDC1B in the development of bladder cancer. The analysis of clinical specimens revealed the upregulated expression of DEPDC1B in bladder cancer, which was positively related to tumor grade. In vitro and in vivo studies showed that DEPDC1B knockdown could inhibit the growth of bladder cancer cells or xenografts in mice. The suppression of bladder cancer by DEPDC1B was executed through inhibiting cell proliferation, cell migration, and promoting cell apoptosis. Moreover, a mechanistic study found that SHC1 may be an important route through which DEPDC1B regulates the development of bladder cancer. Knockdown of SHC1 in DEPDC1B-overexpressed cancer cells could abolish the promotion effects induced by DEPDC1B. In conclusion, DEPDC1B was identified as a key regulator in the development of bladder cancer, which may be used as a potential therapeutic target in the treatment of bladder cancer.

References

Jul 6, 2000·Nature Cell Biology·S Sokol
Sep 23, 2006·Cell·Daniel R BallonJeremy Thorner
Jul 12, 2011·Cancer Cell·Javier E GirardiniGiannino Del Sal
Jun 28, 2014·Biochemical and Biophysical Research Communications·Yi YangMengfeng Li
Jul 30, 2014·Molecular and Cellular Biology·Jesse HudsonJosie Ursini-Siegel
Feb 27, 2015·Cell Biochemistry and Biophysics·Xiaoying ZhangJantai He
Jun 6, 2015·Biochemical and Biophysical Research Communications·Ki Young ChoiSeung Hwan Hong
Jun 22, 2016·European Urology·Marko BabjukRichard Zigeuner
Jul 3, 2016·European Urology·Sebastien AntoniFreddie Bray
Jul 5, 2016·European Urology·J Alfred WitjesMaria J Ribal
Aug 9, 2017·Nature Reviews. Urology·Peter Sidaway
Nov 9, 2017·Nature·Michelle Grayson
Nov 22, 2017·Urologic Oncology·Angela B Smith
Mar 10, 2018·Investigative and Clinical Urology·Xuan-Mei PiaoJayoung Kim
Nov 6, 2018·Journal of Cellular and Molecular Medicine·Xin RuiJiangyong Leng
Feb 28, 2019·Carcinogenesis·Haichao ChaoTao Zeng
Jun 17, 2019·Breast Cancer Research : BCR·Kevin D WrightAndrey Sorokin
Aug 29, 2019·Functional & Integrative Genomics·Tingting ChenXing Xie
May 10, 2020·Genetic Testing and Molecular Biomarkers·Yixin Sun, Zhiming Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
GTPase
transfection
PCR
electrophoresis
Protein Assay
Antibody Array
chip
xenograft
flow cytometry

Software Mentioned

FACScan
SPSS
GLOBOCAN
Limma
GraphPad Prism6
ImageJ

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.